Companies

KIORA PHARMACEUTICALS INC

KPRX, KPHMW · CIK 0001372514 · operating

$2.05-1.85%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$7.58M
P/E
Fwd P/E-0.92
PEG
P/S
P/B0.32
EV/EBITDA1.23
EV/Rev

Profitability

Gross Margin
Op. Margin28.15%
Net Margin22.44%
ROE13.95%
ROA9.85%
FCF Margin53.39%

Financial Health

Current Ratio4.94
Debt/Equity0.42
Free Cash Flow$8.55M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth132.34%
Beta-0.81
52W High$4.18
52W Low$1.765

About KIORA PHARMACEUTICALS INC

KIORA PHARMACEUTICALS INC (KPRX) is a pharmaceutical preparations company, listed on the Nasdaq. With a market capitalization of $8 million, KIORA PHARMACEUTICALS INC is a micro-cap company. The stock currently trades at $2.05, down 1.85% today, with a 52-week range of $1.76–$4.18.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$0.87$0.93+132.3%
2023$-2.69$-2.69+85.5%
2022$-18.55$-18.55-948.0%
2021$-1.77$-1.77
2020
2019
2018
2017
2016
2015

Annual Reports (10-K) · 11 filings

Report DateFiledAccession Number
2024-12-312025-03-250001372514-25-000012SEC ↗
2023-12-312024-03-250001372514-24-000026SEC ↗
2022-12-312023-03-230001372514-23-000050SEC ↗
2021-12-312022-04-150001410578-22-000925SEC ↗
2020-12-312021-03-250001104659-21-041515SEC ↗
2019-12-312020-03-040001104659-20-029162SEC ↗
2018-12-312019-03-010001144204-19-011634SEC ↗
2017-12-312018-03-020001144204-18-012542SEC ↗
2016-12-312017-02-230001144204-17-010635SEC ↗
2015-12-312016-03-300001144204-16-091485SEC ↗
2014-12-312015-03-310001144204-15-020232SEC ↗